Full text is available at the source.
Abstract
This review synthesizes evidence from studies (1984-2025) on the relationship between classical psychedelics and psychotic symptoms.
- Classical psychedelic drugs may be associated with an increased risk of psychotic symptoms in certain individuals.
- Risk factors for psychosis could include personal and family history of mental health issues.
- The prevalence of psychosis related to psychedelic use varies across different populations and substances.
- Clinical characteristics of psychedelics-related psychosis may differ from other forms of psychosis.
- Findings aim to help clinicians and policymakers in identifying and mitigating risks linked to psychedelic use.
Simplified